Skip to content

Clinical trials

Phase 2 Kidney Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Phase: Phase 2 Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20071
20081
20101
20111
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AMAG Pharmaceuticals, Inc.1
AstraZeneca1
Aurinia Pharmaceuticals Inc.1
Dynavax Technologies Corporation1
Hamilton Health Sciences Corporation1
Michael Mauer, MD1
Novartis Pharmaceuticals1
Novo Nordisk A/S1
OPKO IP Holdings II, Inc.1
Otsuka Pharmaceutical Development & Commercialization, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases11
Diabetes Mellitus3
Renal Insufficiency3
Renal Insufficiency, Chronic3
Diabetic Nephropathies2
Anemia1
Anemia, Iron-Deficiency1
Autoimmune Diseases1
Bone Diseases1
Diabetes Mellitus, Type 11

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.